Lymphedema after breast cancer: Regional consensus recommendations for postoperative management, prevention, treatment and follow-up care;Lymphödem bei mammakarzinom: Regionale konsensus-empfehlungen zum postoperativen management, prävention, therapie und nachsorge

Geburtshilfe und Frauenheilkunde

Volumn 65, Issue 10, 2005, Pages 955-965

  Albert, Ute Susann ^a   Seifart, U ^b   Heim, M E ^c   Hubner J ^d   Jungkunz, W ^e   Prokein, R ^f   Rick, O ^g   Hoffmann, M ^h   Engenhart Cabillic, R ^a   Kopp, I ^e   Wagner, U ^a   Kalder, M ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b Rehabilitations Klinik Bellevue   (Germany)

^c Sonnenberg Klinik gGmbH   (Germany)

^d Habichtswald Klinik Kassel   (Germany)

^e Deutschen Gesellschaft für Lymphologie ^*

^f HELIOS William Harvey Klinik   (Germany)

^g Klinik Reinhardshohe   (Germany)

^h DRK Krankenhaus   (Germany)

Author keywords

Breast cancer; Guideline; Lymphedema; Recommendations

Indexed keywords

ALGORITHM; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CONCEPT FORMATION; CONSENSUS; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; LONGITUDINAL STUDY; LYMPHEDEMA; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; MEDICAL INSTRUMENTATION; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PROSPECTIVE STUDY; QUALITY OF LIFE; RECOGNITION;

EID: 27944494774     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872873     Document Type: Article

References (78)

1. Baumeister R, Berens von Rautenfeld H, Bräutigam P, Földi E, Kaiserling E, Martin K, Werner J. AWMF Leitlinie zur Diagnostik und Therapie der Gliedmaßen Lymphödeme. Leitlinie der Gesellschaft deutschsprachiger Lymphologen, 2000. http://www.leitlinien.de
2. Werner T, Reißhauer A. AWMF-Leitlinie Stufe 1 zur Behandlung des Lymphödems. Leitlinie der Deutschen Gesellschaft für Physikalische Medizin und Rehabilitation, 1998. http://www.leitlinien.de
3. Kwan W, Jackson J, Weir L, Dingee C, McGregor G, Olivotto I. Chronic arm morbidity after curative breast cancer treatment: Prevalence and impact on quality of life. J Clin Oncol 2002; 20: 4242-4248
4. Reitman J, Dijkstra P, Hoekstra H, Wisma W, Szabo B, Groothoff J, Geertzen J. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 2003; 29: 229-238
5. Petrek J, Heelan M. Incidence of breast carcinoma-related lymphedema. Cancer 1998; 83: 2778
6. Maunsell E, Brisson B, Deschness L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993; 36: 315-320
7. Tengrup I, Tennvall-Nittby L, Christiansson I, Laurin M. Arm morbidity after breast-conserving therapy for breast cancer patients. Acta Oncol 2000; 39: 393-397
8. Petrek J, Senie R, Peters M, Rosen P. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001; 92: 1368-1377
9. Liljegren G, Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage 1. Results from a randomised trial. Eur J Cancer 1997; 33: 193-199
10. Yap KPL, McCready DR, Narod S, Manchul LA, Trudeau M, Fyles A. Factors influencing arm and axillary symptoms after treatment for node negative breast carcinoma. Cancer 2003; 97: 1369-1375
11. Ernst M, Voogd A, Balder W, Klinkenbijl J, Roukem J. Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol 2002; 79: 151-155
12. Tasmuth T, von Smitten K, Kalso E. Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer 1996; 74: 2024-2031
13. Cohen L, Hack T, de Moor C, Katz J, Goss P. The effects of type of surgery and time on psychological adjustment in women after breast cancer treatment. Ann Surg Oncol 2000; 7: 427-434
14. Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona C. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 2001; 92: 1783-1787
15. Fajardo L. Effects of ionizing radiation on lymph nodes. A review. Front Radiat Ther Oncol 1994; 28: 45
16. Schunemann H, Willich N. Lymphedema after breast carcinoma. A study of 5868 cases. Dtsch Med Wochenschr 1997; 122: 536-541
17. Albert U, Koller M, Schulz K, Wagner U. Outcome matters: Quality of life and the harm of axillary surgery in lymph node negative patients with breast cancer. Zentralbl Gynaekol 2003; 125: 526
18. Hack T, Cohen L, Katz J, Robson L, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999; 17: 143-149
19. Kühn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I, Kreienberg R. Long-term morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for quality of life and the impact on demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 2000; 64: 275-286
20. Ververs J, Roumen R, Vingerhoets A, Vreugdenhil G, Coebergh J, Crommelin M, Luiten E, Repelaer van Driel O, Schijven M, Voogd A. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001; 37: 991-999
21. Taylor K. Morbidity associated with axillary surgery for breast cancer. Aust NZJ Surg 2004; 74: 314-317
22. Johansson K, Ingvar C, Alertsson M, Ekdahl C. Arm lymphoedema, shoulder mobility and muscle strength after breast cancer treatment - a prospective 2 year study. Advances in Physiotherapy 2001; 3: 55-66
23. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D. Axillary surgery severley affects quality of life: results of a 5 year prospective study in breast cancer patients. Breast Cancer Res Treat 2003; 79: 47-57
24. Albert US, Koller M, Lorenz W, Schulz K, Wagner U. Arm morbidity after axillary lymphadenectomy for primary breast cancer: Results from a population-based cohort study. Ann Surg 2005; (Submitted)
25. World Health Organisation (WHO). National Cancer Control Programms: Policies and managerial Guidelines. 2nd ed. Geneva, Italy: Health and Development Networks (HDN), 2002
26. Sozialgesetzbuch (SGB) Fünftes Buch (V) BGBBI. I S. 2477,2482. 22.6. 2005 BGBI. IS. 1720.20-12-1988.1-7-0005
27. Verordnung über das Verfahren zum Risikostrukturausgleich in der gesetzlichen Krankenversicherung (Risikostruktur-Ausgleichsverordnung - RSAV) BGBI. 11994, Nr. I, S 55. der Siebten Verordnung zur Änderung der Risikostruktur-Ausgleichsverordnung BGBI. 12003, Nr. 16, S 553. 3-1-1994. Anforderungen an die Ausgestaltung von strukturierten Behandlungsprogrammen für Patientinnen mit Brustkrebs. 4. Verordnung zur Änderung der Risikostruktur-Ausgleichsverordnung (4.RSA-ÄndV) 27.6.2002. 28-4-2003
28. Gemeinsamer Bundesausschuss. Empfehlung des Gemeinsamen Bundesausschusses nach § 91 Absatz 4 gemäß § 137 f Absatz 2 SGB V: Anforderungen an strukturierte Behandlungsprogramme für Brustkrebs. Aktualisierung auf dem Beschluss des Koordinierungsausschusses vom 13.6.2002 und der Vierten Verordnung zur Änderung der Risikostrukturvergleichsordnung vom 27.6.2002. Beschluss vom 21.6.2005
29. Lorenz W, Ollenschläger G, Geraedts M, Gerlach F, Gangjour A, Helou A, Kirchner H, Koller M, Lauterbach W, Reinauer H, Sitter H, Thomeczek C. Das Leitlinien Manual: Entwicklung und Implementierung von Leitlinien in der Medizin. ZaeFQ 2001; 95 (Suppl): 1-84
30. Delbecq AL, Van de Ven AH, Gustafson DH. Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes. New York, USA: Scott, Foresman and Company, 1975
31. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M et al. Treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365
32. Payers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels: EORTC Study Group on Quality of Life, 2001
33. Kreienberg R et al. Interdisziplinäre Stufe-3-Leitlinien Diagnose, Therapie und Nachsorge des Mammakarzinoms. München: Zuckschwerdtverlag, 2004
34. Jungkunz W, Wörmann P, Gatzenberger R. Ambulante Betreuung lymphologischer Patienten. Lymphologie in Forschung und Praxis 2001; 5: 84-93
35. Sozialgesetzbuch: Fünftes Sozialgesetzbuch (SGB V), 1999
36. Erickson V, Pearson M, Ganz P, Adams J, Kahn K. Arm edema in breast cancer patients. J Natl Cancer Inst 2001; 93: 96-111
37. Engel J, Nagel G, Breuer E, Meisner C, Albert U-S et al. Primary breast cancer therapy in six regions of Germany. Eur J Cancer 2002; 38: 578-585
38. du Bois A, Misselwitz B, Stillger R, Jackisch C, Schwab R, Gnauert K, Hills R, Wagner U. Versorgungsstruktur und Qualität bei der Behandlung des Mammakarzinoms. Eine Untersuchung am Beispiel der Daten aus Hessen 1996-2002. Geburtsh Frauenheilk 2003; 63: 743-751
39. du Bois A, Misselwitz B, Wagner U, König K, Schneidewind G, Jackisch C, Hoffmann G. Disease-Management-Program (DMP) - breast cancer and pattern of care with respect to surgical therapy in Hessen 2002. Geburtsh Frauenheilk 2004; 64: 261-270
40. Michaelson J, Satija S, Kopan D, Moore R, Silverstein M, Comegno A, Hughes K, Taghian A, Powell S, Smith B. Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. Cancer 2003; 96: 2114-2124
41. Michaelson J, Silverstein M, Sgroi D, Cheongsiatmy J, Taghian A, Powell S, Hughes K, Comegno A, Tanabe K, Smith B. The effect of tumor size and lymph node status on breast cancer lethality. Cancer 2003; 98: 2133-2143
42. Verschraegen C, Vinh-Hung V, Cserni G, Gordon R, Royce M, Vlastos G, Tai P, Storme G. Modeling the effect of tumor size and early breast cancer. Annals of Surgery 2005; 241: 309-318
43. Cheville A, McGarvey C, Petrek J, Russo S, Thiadens S, Taylor M. The grading of lymhedema in oncology clinical trials. Sem Radiation Oncol 2003; 13: 214-225
44. International Society of Lymphology. The diagnosis of peripheral edema: consensus document of the Internatinal Society of Lymphology Executive Committee. Lymphology 1995; 28: 113-117
45. Boris M, Weindorf S, Lasinski B. Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Oncology 1997; 11: 99-109
46. Harris S, Hugi M, Olivetto I, Niessen-Vertommen S, Dingee C, Eddy F, Allan S, Haylock B, Kwan W. Upper extremity rehabilitation in women with breast cancer after axillary dissection: clinical practice guideline. Critical Review in Physical Medicine and Rehabilitation 2001; 13: 91-103
47. Karki A, Simonen R, Malkia E, Selfe J. Efficacy of physical therapy methods and exercise after breast cancer operation: a systematic review. Critical Review in Physical Medicine and Rehabilitation 2001; 13: 159-190
48. Bendz I, Fagevik Olsen M. Evaluation of immediate versus delayed shoulder excercise after breast cancer surgery including lymph node dissection - a randomized controlled trial. Breast 2002; 11: 241-248
49. Box R, Reul-Hirche H, Bullock-Saxton J, Furnival C. Shoulder movement after breast cancer surgery: results of a randomised controlled study of postoperative physiotherapy. Breast Cancer Res and Treat 2002; 75: 35-50
50. McNeely M, Campbell K, Courneya K, Dabbs K, Klassen T, Mackey Ospina M, Rowe B. Exercise interventions for upper limb dysfunction due to breast cancer surgery (protocol). The Cochrane Database of Systematic Reviews 2005; 2. Art. No.: CD005211
51. Wienert V, Waldermann F, Zabel M, Rabe E, Jünger M. AWMF Leitlinie Stufe 1: Medizinischer Kompressionsstrumpf (MKS). http:// www.leitlinien.de
52. Rockson S, Miller L, Senie R, Brennan M, Casley-Smith J, Földi E et al. American cancer society lymphedema workshop. Workshop III: Diagnosis and management of lymphedema. Cancer 1998; 83 (Suppl 12): 2882-2885
53. Földi E. The treatment of lymphoedema. Cancer 2005; 83 (Suppl): 2833-2834
54. Bunce I, Miroli B, HennesyJ, Ward L, Jones L. Postmastectomy lymphedema treatment and measurement. Med J Aust 1994; 161: 125-128
55. Leduc O, Leduc A, Bourgeois P, Belgrade J. The physical treatment of upper limb edema. Cancer 1998; 83: 2835-2839
56. Casley-Smith J. Alteration of untreated lymphedema and its grades over time. Lymphology 1995; 28: 174-185
57. Megans A, Harris S. Physical therapist management of lymphedema following treatment for breast cancer: a critical review. Phy Ther 1998; 78: 1302-1311
58. Howell D, Ezzo J, Tuppo K, Bily L, Johannson K. Complete decongestive therapy for lymphedema following breast cancer treatment (Protocol). The Cochrane Database of Systematic Reviews 2002; 1. Art. No:CD003475
59. Anderson L, Hojris I, Erlandsen M, Andersen J. Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage - a randomized study. Acta Oncol 2000; 39: 399-405
60. Badger C, Peacock J, Mortimer P. A randomized, controlled, parallel-group clinical trial comparing multilayer bandaging followed by hosiery versus hosiery alone in treatment of patients with lymphedema of the limb. Cancer 2000; 88: 2832-2837
61. Hornsby R. The use of compression to treat lymphedema. Professional Nurse 1995; 11: 127-128
62. Brüggemann S. Das Reha-Leitlinien-Programm der BfA. Z ärztl Fortbild Qual Gesundh wes 2005; 99: 47-50
63. Klosterhuis H. Rehabilitation-Leitlinien als Instrument der Qualitätssicherung der Rehabilitation. Z ärztl Fortbild Qual Gesundh wes 2005;99:41-45
64. Gülich B. Leitlinienentwicklung in der Rehabilitation bei Rückenschmerzpatientinnen - Phase 2: Ergebnisse einer Analyse der KTL-Daten. Rehabilitation 2003; 42: 109-116
65. Raspe H. Indikationsleitlinien zur Rehabilitation im Kontext von Disease-Management-Programmen. Z ärztl Fortbild Qual Gesundh wes 2005; 99: 35-40
66. Richtlinien des Gemeinsamen Bundesausschusses über Leistungen zur medizinischen Rehabilitation (Rehabilitations-Richtlinie) nach § 92 Abs. 1 Satz 2 N. 8 SGB V in der Fassung vom 16. März 2004 (BAnz. S 6769). Deutsches Ärzteblatt 2004; 101: A1194-A1200
67. Cabana MD, Rand CS, Owe NR et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-1465
68. Albert US, Koller M, Lorenz W, Kopp I, Heitmann C, Stinner B, Rothmund M, Schulz K. Quality of life-profile: from measurement to clinical application. Breast 2002; 11: 324-334
69. Middecke M, Bauhofer A, Kopp I, Koller M. Computerized visualisation of quality of life data of individual cancer patients - the QoL-Profiler. Inflamm res 2004; 53 (Suppl 2): 175-178
70. Margolis CZ. Methodology matters VII. Clinical practice guidelines: methodological considerations. Int J Qual Health Care 1997; 9: 303-306
71. Grimshaw J, Thomas R, MacLennan G, Fraser C, Ramsay C, Vale L et al. Effectiveness and efficacy of guideline dissemination and implementation strategies. Health Technology Assessment 2004; 8: 1-102
72. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change. Lancet 2003; 362: 1225-1230
73. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998; 317: 465-468
74. Gross PA, Greenfield S, Cretin S et al. Optimal methods for guideline implementation: Conclusions from Leeds Castle meeting. Med Care 2001; 39 (Suppl 2): 1185-1192
75. Albert U, Koller M, Lorenz W, Doherty J, Schulz K, Wagner U, Kopp I. Implementierung und Evaluation von Leitlinien auf nationaler Ebene: Entwicklung eines Konzeptes für die Stufe 3-Leitlinie Brustkrebs-Früherkennung in Deutschland. ZaeFQ 2004; 98: 347-359
76. Lorenz W. Outcome: Definition and methods of evaluation. In: Troidl H, McKneally MF, Mulder DS, Wechsler AS et al (eds). Surgical Research Basic Principles and Clinical Practice. 3rd ed. New York: Springer, 1998: 513
77. Kopp I, Encke A, Lorenz W. Leitlinien als Instrument der Qualitätssicherung in der Medizin. Bundesgesundheitsbl-Gesundheitsforsch- Gesundheitsschutz 2002; 45: 223-233
78. Delbecq AL, Van de Ven AH, Gustafson DH. Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes. New York, USA: Scott, Foresman and Company, 1975